Matches in SemOpenAlex for { <https://semopenalex.org/work/W2564783979> ?p ?o ?g. }
- W2564783979 endingPage "2542" @default.
- W2564783979 startingPage "2529" @default.
- W2564783979 abstract "To study ROCK2 activation in carcinogenesis, mice expressing 4-hydroxytamoxifen (4HT)-activated ROCK2 (K14.ROCKer) were crossed with mice expressing epidermal-activated rasHa (HK1.ras1205). At 8 weeks, 4HT-treated K14.ROCKer/HK1.ras1205 cohorts exhibited papillomas similar to HK1.ras1205 controls; however, K14.ROCKer/HK1.ras1205 histotypes comprised a mixed papilloma/well-differentiated squamous cell carcinoma (wdSCC), exhibiting p53 loss, increased proliferation and novel NF-κB expression. By 12 weeks, K14.ROCKer/HK1.ras1205 wdSCCs exhibited increased NF-κB and novel tenascin C, indicative of elevated rigidity; yet despite continued ROCK2 activities/p-Mypt1 inactivation, progression to SCC required loss of compensatory p21 expression. K14.ROCKer/HK1.ras1205 papillomatogenesis also required a wound promotion stimulus, confirmed by breeding K14.ROCKer into promotion-insensitive HK1.ras1276 mice, suggesting a permissive K14.ROCKer/HK1.ras1205 papilloma context (wound-promoted/NF-κB+/p53−/p21+) preceded K14.ROCKer-mediated (p-Mypt1/tenascin C/rigidity) malignant conversion. Malignancy depended on ROCKer/p-Mypt1 expression, as cessation of 4HT treatment induced disorganized tissue architecture and p21-associated differentiation in wdSCCs; yet tenascin C retention in connective tissue extracellular matrix suggests the rigidity laid down for conversion persists. Novel papilloma outgrowths appeared expressing intense, basal layer p21 that confined endogenous ROCK2/p-Mypt1/NF-κB to supra-basal layers, and was paralleled by restored basal layer p53. In later SCCs, 4HT cessation became irrelevant as endogenous ROCK2 expression increased, driving progression via p21 loss, elevated NF-κB expression and tenascin C-associated rigidity, with p-Mypt1 inactivation/actinomyosin-mediated contractility to facilitate invasion. However, p21-associated inhibition of early-stage malignant progression and the intense expression in papilloma outgrowths, identifies a novel, significant antagonism between p21 and rasHa/ROCK2/NF-κB signalling in skin carcinogenesis. Collectively, these data show that ROCK2 activation induces malignancy in rasHa-initiated/promoted papillomas in the context of p53 loss and novel NF-κB expression, whereas increased tissue rigidity and cell motility/contractility help mediate tumour progression." @default.
- W2564783979 created "2017-01-06" @default.
- W2564783979 creator A5006715800 @default.
- W2564783979 creator A5022119524 @default.
- W2564783979 creator A5033277700 @default.
- W2564783979 creator A5060240105 @default.
- W2564783979 date "2016-12-19" @default.
- W2564783979 modified "2023-09-30" @default.
- W2564783979 title "ROCK2/rasHa co-operation induces malignant conversion via p53 loss, elevated NF-κB and tenascin C-associated rigidity, but p21 inhibits ROCK2/NF-κB-mediated progression" @default.
- W2564783979 cites W1562863690 @default.
- W2564783979 cites W1741173293 @default.
- W2564783979 cites W1768917741 @default.
- W2564783979 cites W1868626511 @default.
- W2564783979 cites W1967382905 @default.
- W2564783979 cites W1969564302 @default.
- W2564783979 cites W1971922932 @default.
- W2564783979 cites W1971964944 @default.
- W2564783979 cites W1989135470 @default.
- W2564783979 cites W1992216304 @default.
- W2564783979 cites W1995424242 @default.
- W2564783979 cites W2007456673 @default.
- W2564783979 cites W2008324315 @default.
- W2564783979 cites W2008933923 @default.
- W2564783979 cites W2012830649 @default.
- W2564783979 cites W2015985931 @default.
- W2564783979 cites W2021328900 @default.
- W2564783979 cites W2030649154 @default.
- W2564783979 cites W2034261911 @default.
- W2564783979 cites W2037611415 @default.
- W2564783979 cites W2039430052 @default.
- W2564783979 cites W2039836591 @default.
- W2564783979 cites W2045254664 @default.
- W2564783979 cites W2047401805 @default.
- W2564783979 cites W2061096783 @default.
- W2564783979 cites W2062711303 @default.
- W2564783979 cites W2069068063 @default.
- W2564783979 cites W2071080821 @default.
- W2564783979 cites W2077810031 @default.
- W2564783979 cites W2083543572 @default.
- W2564783979 cites W2086336177 @default.
- W2564783979 cites W2089701744 @default.
- W2564783979 cites W2093937463 @default.
- W2564783979 cites W2099170646 @default.
- W2564783979 cites W2102067890 @default.
- W2564783979 cites W2106572080 @default.
- W2564783979 cites W2107462637 @default.
- W2564783979 cites W2108905204 @default.
- W2564783979 cites W2118986158 @default.
- W2564783979 cites W2134542375 @default.
- W2564783979 cites W2143348495 @default.
- W2564783979 cites W2144216187 @default.
- W2564783979 cites W2153696346 @default.
- W2564783979 cites W2158444028 @default.
- W2564783979 cites W2168091755 @default.
- W2564783979 cites W2168095422 @default.
- W2564783979 cites W2169328538 @default.
- W2564783979 cites W2989203287 @default.
- W2564783979 doi "https://doi.org/10.1038/onc.2016.402" @default.
- W2564783979 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27991921" @default.
- W2564783979 hasPublicationYear "2016" @default.
- W2564783979 type Work @default.
- W2564783979 sameAs 2564783979 @default.
- W2564783979 citedByCount "10" @default.
- W2564783979 countsByYear W25647839792017 @default.
- W2564783979 countsByYear W25647839792018 @default.
- W2564783979 countsByYear W25647839792019 @default.
- W2564783979 countsByYear W25647839792020 @default.
- W2564783979 countsByYear W25647839792021 @default.
- W2564783979 countsByYear W25647839792022 @default.
- W2564783979 crossrefType "journal-article" @default.
- W2564783979 hasAuthorship W2564783979A5006715800 @default.
- W2564783979 hasAuthorship W2564783979A5022119524 @default.
- W2564783979 hasAuthorship W2564783979A5033277700 @default.
- W2564783979 hasAuthorship W2564783979A5060240105 @default.
- W2564783979 hasBestOaLocation W25647839792 @default.
- W2564783979 hasConcept C117961784 @default.
- W2564783979 hasConcept C121608353 @default.
- W2564783979 hasConcept C189165786 @default.
- W2564783979 hasConcept C203014093 @default.
- W2564783979 hasConcept C2777738151 @default.
- W2564783979 hasConcept C2780269544 @default.
- W2564783979 hasConcept C502942594 @default.
- W2564783979 hasConcept C518705261 @default.
- W2564783979 hasConcept C54355233 @default.
- W2564783979 hasConcept C555283112 @default.
- W2564783979 hasConcept C86492073 @default.
- W2564783979 hasConcept C86803240 @default.
- W2564783979 hasConcept C95444343 @default.
- W2564783979 hasConceptScore W2564783979C117961784 @default.
- W2564783979 hasConceptScore W2564783979C121608353 @default.
- W2564783979 hasConceptScore W2564783979C189165786 @default.
- W2564783979 hasConceptScore W2564783979C203014093 @default.
- W2564783979 hasConceptScore W2564783979C2777738151 @default.
- W2564783979 hasConceptScore W2564783979C2780269544 @default.
- W2564783979 hasConceptScore W2564783979C502942594 @default.
- W2564783979 hasConceptScore W2564783979C518705261 @default.
- W2564783979 hasConceptScore W2564783979C54355233 @default.
- W2564783979 hasConceptScore W2564783979C555283112 @default.